Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Neuro-Oncology is Scopus-indexed (Q2, CiteScore 5.5), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 0167-594XVerify ISSN ↗1573-7373Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$4,590 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 114 / 403 | 71st | Q2 |
| Neurology | 61 / 201 | 69th | Q2 |
| Oncology | 135 / 428 | 68th | Q2 |
| Cancer Research | 110 / 233 | 52nd | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1983–present, best quartile Q2, CiteScore 5.5.
Journal of Neuro-Oncology is Q2 in Neurology (clinical) (rank 114 of 403), Q2 in Neurology (rank 61 of 201) and Q2 in Oncology (rank 135 of 428), by CiteScore 2025. It is ranked in 4 subject areas in all.
Journal of Neuro-Oncology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.5, which places it in quartile Q2 at the 71st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.030, quartile Q2, with an H-index of 147.
The publisher lists an article processing charge of about US$4,590 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Neuro-Oncology is published by Springer. Its print ISSN is 0167-594X and its online ISSN is 1573-7373.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Neuro-Oncology has an h-index of 165 and a 2-year mean of 3.01 citations per paper (OpenAlex). Its Scopus CiteScore is 5.5, quartile Q2. On 2-year citations it ranks #82 of 403 Scopus journals in Neurology (clinical).
Journal of Neuro-Oncology published 471 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2026), authors are most often from United States (38.6%), Germany (9.4%) and China (6.1%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 26 retracted papers are recorded (2.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.